Leaflet IXEL 25mg capsules
Indicated for: depression; fibromyalgia
Route of administration: oral
Substance: milnacipran (serotonin-norepinephrine reuptake inhibitor)
ATC: N06AX17 (Nervous system | Antidepressants | Other antidepressants)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Seek medical help if suicidal thoughts or major behavior changes occur.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
This medicine may change blood electrolyte levels.
Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of fibromyalgia and major depressive disorder. It works by increasing the levels of these neurotransmitters in the brain, helping to alleviate pain and depressive symptoms.
The medication is taken orally, usually twice daily, with the dose adjusted based on the patient's response. Common side effects include nausea, dizziness, insomnia, and excessive sweating.
Milnacipran is contraindicated in patients with severe renal impairment, uncontrolled hypertension, or hypersensitivity to the active substance. Its use also requires caution in patients at risk of suicide or with cardiovascular conditions.
This medication is an effective option for managing fibromyalgia and depression, helping to improve patients' quality of life.
General data about IXEL 25mg
- Substance: milnacipran
- Date of last drug list: 01-07-2015
- Commercial code: W04338001
- Concentration: 25mg
- Pharmaceutical form: capsules
- Quantity: 56
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for milnacipran
- 25mg
- 50mg